Paul Predki

Paul Predki is an accomplished biotechnology executive with extensive experience in research and development across various leading companies. Currently serving as CTO and Head of Research at Iridia, Inc., Predki is involved in pioneering semiconductor-based technology for DNA data management. As Chair of the Scientific Advisory Board at Rational Vaccines and a Partner at Gen10 Bioscience, Predki contributes to vaccine development and life science research tools. Previous roles include Chief Scientific Officer at Curate Biosciences, VP of R&D at Life Technologies and Invitrogen, and Associate Director at the DOE Joint Genome Institute, where significant contributions were made to the Human Genome Project. Paul Predki holds a Ph.D. in Biochemistry from the University of Toronto and has completed post-doctoral studies at Yale University.